BRIEF-Hikma Pharma to buy Ben Venue's generic injectables factory

July 24 Thu Jul 24, 2014 4:25am EDT

July 24 (Reuters) - Hikma Pharmaceuticals Plc

* Agreed with Ben Venue Laboratories, Inc. , part of Boehringer Ingelheim Group of companies, to acquire their generic injectables manufacturing site in Bedford, Ohio

* No incremental consideration is payable in relation to Hikma acquiring Ben Venue manufacturing site.

* All manufacturing at Ben Venue site was ceased in December

* Acquisition of assets expected to be slightly dilutive to adjusted EPS in 2014, 2015 and strongly accretive to adjusted EPS from 2016 Source text for Eikon: Further company coverage: